Core One Labs' Akome Reveals Impressive Results for its Psyc

Core One Labs' Akome Reveals Impressive Results for its Psychedelic Bio-Compounds Designed to Target Alzheimer's and Parkinson's, Showing Potential to Outperform Current Treatment Methods

Core One Labs' Akome Reveals Impressive Results for its Psychedelic Bio-Compounds Designed to Target Alzheimer's and Parkinson's, Showing Potential to Outperform Current Treatment Methods

bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Vancouver , British Columbia , Canada , Canadian , Akome Bio , Joel Shacker , Core One Labs Inc , Health Canada , Vocan Biotechnologies Inc , Canadian Securities Exchange , Core One Lab , Akome Biotech Ltd , Akome Biotechnologies Inc , Biosciences Inc , Core One Labs , Core One , Universitat De Barcelona , Akome Biotechnologies , Psychedelic Compound , Alzheimer Disease , Ischemic Stroke , Akome Bio Compounds , One Labs , Awakened Biosciences Inc , Controlled Drugs , Substances Act ,